AzTrials
AzTrials

Post-traumatic Stress Disorder (PTSD)Phase 2NCT01729325

Prevention of Post-Traumatic Stress Disorder in Soldiers

A Phase 2 study testing Preventive Narrative Exposure Therapy in people with Post-traumatic Stress Disorder (PTSD) and Aggressive Behavior, run by University of Konstanz at 1 site in Burundi.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Soldiers in conflict or former conflict regions deployed in peace-keeping missions were and are often exposed to multiple traumatic events and situations in which they are forced to engage in violent behavior. Read more about this study

Who is it for?
Ages 20 to 60 years, men onlyHealthy volunteers can take part
What is being tested?
Preventive Narrative Exposure Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
118 participants
Where
1 siteBurundi
Study dates
Nov 2012to Apr 2015
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Exposure to traumatic experiences derived from expert interviews with scores of the Traumatic Life Event List for War and Torture
  • Soldiers are part of the Burundian army and of the joint African Union and United Nations peacekeeping mission in Somalia (AMISOM)

Who cannot join

  • Current use of mind altering drugs
  • Psychotic symptoms

Trial locations and contacts

1 site in 1 country.

Burundi1 site
  • Burundian Army (FDN)

    Bujumbura, Bujumbura Mairie Province

About this study

Official title: Prevention of Post-Traumatic Stress Disorder in Relation to Appetitive Aggression in Burundian Soldiers Deployed in a Peace-keeping Mission in Somalia

Soldiers in conflict or former conflict regions deployed in peace-keeping missions were and are often exposed to multiple traumatic events and situations in which they are forced to engage in violent behavior. The Preventive Narrative Exposure Therapy (Pre-NET) aims to reinforce resilience thereby reducing the risk of developing or aggravating PTSD or other mental disorders as a result of traumatic experiences. The effective prevention of mental disorders as a result of war deployment is expected to facilitate reintegration in civil life after deployment and reduce uncontrolled violence.

Being tested
Preventive Narrative Exposure Therapy
Keywords
Post-traumatic Stress disorder (PTSD), Aggressive Behavior, Appetitive Aggression, Resilience, Preventive Narrative Exposure Therapy
Medical subject headings
Stress Disorders, Post-Traumatic, Aggression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Preventive Narrative Exposure TherapyBehavioural

    During Pre-NET the client, with the assistance of the therapist, constructs a chronological narrative of his whole life with a focus on exposure to traumatic stress. Empathic understanding, active listening, congruency and unconditional positive regard are key components of the therapist's behavior who asks in detail for emotions, cognitions, sensory information, and physiological reactions, linking them to an autobiographical context. During two sessions a chronological overview of the whole life with a focus on traumatic events is developed and the most important traumatic experiences are processed.

Study groups in NCT01729325
Study groupRoleWhat they receive
Preventive Narrative Exposure TherapyExperimentalTreatment with Pre-NET before deployment in peace-keeping mission
Receives: Behavioral: Preventive Narrative Exposure Therapy
No treatment controlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Severity of traumatic symptoms measured via the Post-traumatic Stress Disorder Scale-Interview (PSS-I)

    Measured: 15 months

  2. Extend of appetitive aggression via the Appetitive Aggressions Scale (AAS)

    Measured: 15 months

Secondary outcomes (3)
  1. Severity of depressive symptoms measured via the Patient Health Questionnaire-9 (PHQ-9)

    Measured: 15 months

  2. Strength of suicidal ideation measured via the MINI

    Measured: 15 months

  3. Physical health complains

    Measured: 15 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2012 (estimated)
  2. Study startNov 2012
  3. Primary completionJan 2013
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
118 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01729325
Sponsor's protocol ID
UKULBUSO2012
Status last verified
Jun 2015
First submitted
13 Nov 2012
Last updated
4 Jun 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Preventive Narrative Exposure Therapy in people with Post-traumatic Stress Disorder (PTSD) and Aggressive Behavior, run by University of Konstanz at 1 site in Burundi.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Burundi. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Severity of traumatic symptoms measured via the Post-traumatic Stress Disorder Scale-Interview (PSS-I) (time frame: 15 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in